Report Sellers has added a new market research report “Aptamers – Global Market Outlook (2017-23)” to its offerings.
According to Report, Global Aptamers Market is expected to grow from $128.80 million in 2016 to reach $408.14 million by 2023 with a CAGR of 17.9%. Rising investments in R&D of biotechnology and pharmaceutical industries, technological advancements and high efficient and cost-reduced process for binding larger molecules as compared to antibodies are the some of the key factors propelling the market growth. However, lack of awareness about the technology in developing economies and inadequate regulatory structure are hampering the market. The increased applications of aptamers in the food and chemicals industries are expected to create huge opportunities for market growth.
By product, the DNA aptamers are expected to have huge potential in the diagnosis and treatment of human disorder. DNA aptamers are generally used for the diagnosis of infectious disorder, cancer and cardiovascular disorder. DNA aptamers are oligonucleotides that bind to a variety of targets, such as small molecules, oligosaccharides, peptides, proteins, and cells. They are generated by an evolutionary engineering method called SELEX, using an oligonucleotide library with a randomized sequence. Once DNA aptamer sequences are obtained by SELEX, the aptamers can be chemically synthesized on a large GMP scale, for diagnostic and therapeutic applications.
Geographically, North America holds the largest market shareduring the forecast period. Technological advancements, huge investments in R&D and developments in Aptamers are the major factors contributing to the growth of the market in this region.
Some of the key players in the Aptamers market are Aptamer Solutions Ltd, Somalogic, Inc., Vivonics, Inc, Aptus Biotech S.L, Base Pair Biotechnologies, Inc, Aptagen, LLC , Trilink Biotechnologies, Inc, Aptamer Sciences Inc, Neoventures Biotechnology Inc, Am Biotechnologies, LLC, NOXXON Pharma, Ophthotech Corporation , Novartis AG, NeoNeuro SAS and Apta Targets.
Browse through the complete description and in-depth TOC on “Global Aptamers Market”
What does the Report Offers
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Global Aptamers Market has been segmented by technologies covered, applications covered, aptamers types covered, end users covered and regions covered
Research and Development
End Users Covered:
Contract Research Organizations
Academic and Government Research Institutes
Biotechnology and Pharmaceutical Companies
Other End Users
Aptamers Types Covered:
Nucleic Acid Aptamers
Rest of Europe
Rest of Asia Pacific
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
We have a large number of reports in healthcare Industry which can be accessed in the following link: https://www.reportsellers.com/category/healthcare-market-research-report
About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries. Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
For more information, contact